questionsmedicales.fr
Système nerveux
Système nerveux central
Encéphale
Prosencéphale
Télencéphale
Cerveau
Noyaux gris centraux
Noyaux gris centraux : Questions médicales fréquentes
Termes MeSH sélectionnés :
Medical Order Entry Systems
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Noyaux gris centraux : Questions médicales les plus fréquentes",
"headline": "Noyaux gris centraux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Noyaux gris centraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-25",
"dateModified": "2025-02-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Noyaux gris centraux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cerveau",
"url": "https://questionsmedicales.fr/mesh/D054022",
"about": {
"@type": "MedicalCondition",
"name": "Cerveau",
"code": {
"@type": "MedicalCode",
"code": "D054022",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Amygdale (système limbique)",
"alternateName": "Amygdala",
"url": "https://questionsmedicales.fr/mesh/D000679",
"about": {
"@type": "MedicalCondition",
"name": "Amygdale (système limbique)",
"code": {
"@type": "MedicalCode",
"code": "D000679",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.152"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Groupe nucléaire basolatéral",
"alternateName": "Basolateral Nuclear Complex",
"url": "https://questionsmedicales.fr/mesh/D066272",
"about": {
"@type": "MedicalCondition",
"name": "Groupe nucléaire basolatéral",
"code": {
"@type": "MedicalCode",
"code": "D066272",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.152.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Noyau central de l'amygdale",
"alternateName": "Central Amygdaloid Nucleus",
"url": "https://questionsmedicales.fr/mesh/D066274",
"about": {
"@type": "MedicalCondition",
"name": "Noyau central de l'amygdale",
"code": {
"@type": "MedicalCode",
"code": "D066274",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.152.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Groupe nucléaire cortico-médial",
"alternateName": "Corticomedial Nuclear Complex",
"url": "https://questionsmedicales.fr/mesh/D066276",
"about": {
"@type": "MedicalCondition",
"name": "Groupe nucléaire cortico-médial",
"code": {
"@type": "MedicalCode",
"code": "D066276",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.152.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Claustrum",
"alternateName": "Claustrum",
"url": "https://questionsmedicales.fr/mesh/D000079482",
"about": {
"@type": "MedicalCondition",
"name": "Claustrum",
"code": {
"@type": "MedicalCode",
"code": "D000079482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Corps strié",
"alternateName": "Corpus Striatum",
"url": "https://questionsmedicales.fr/mesh/D003342",
"about": {
"@type": "MedicalCondition",
"name": "Corps strié",
"code": {
"@type": "MedicalCode",
"code": "D003342",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Globus pallidus",
"alternateName": "Globus Pallidus",
"url": "https://questionsmedicales.fr/mesh/D005917",
"about": {
"@type": "MedicalCondition",
"name": "Globus pallidus",
"code": {
"@type": "MedicalCode",
"code": "D005917",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.397"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Néostriatum",
"alternateName": "Neostriatum",
"url": "https://questionsmedicales.fr/mesh/D017072",
"about": {
"@type": "MedicalCondition",
"name": "Néostriatum",
"code": {
"@type": "MedicalCode",
"code": "D017072",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.550"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Noyau caudé",
"alternateName": "Caudate Nucleus",
"url": "https://questionsmedicales.fr/mesh/D002421",
"about": {
"@type": "MedicalCondition",
"name": "Noyau caudé",
"code": {
"@type": "MedicalCode",
"code": "D002421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.550.184"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Putamen",
"alternateName": "Putamen",
"url": "https://questionsmedicales.fr/mesh/D011699",
"about": {
"@type": "MedicalCondition",
"name": "Putamen",
"code": {
"@type": "MedicalCode",
"code": "D011699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.550.784"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Noyau caudé",
"alternateName": "Caudate Nucleus",
"url": "https://questionsmedicales.fr/mesh/D002421",
"about": {
"@type": "MedicalCondition",
"name": "Noyau caudé",
"code": {
"@type": "MedicalCode",
"code": "D002421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.550.184"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Putamen",
"alternateName": "Putamen",
"url": "https://questionsmedicales.fr/mesh/D011699",
"about": {
"@type": "MedicalCondition",
"name": "Putamen",
"code": {
"@type": "MedicalCode",
"code": "D011699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.550.784"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Striatum ventral",
"alternateName": "Ventral Striatum",
"url": "https://questionsmedicales.fr/mesh/D066328",
"about": {
"@type": "MedicalCondition",
"name": "Striatum ventral",
"code": {
"@type": "MedicalCode",
"code": "D066328",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.775"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Noyau accumbens",
"alternateName": "Nucleus Accumbens",
"url": "https://questionsmedicales.fr/mesh/D009714",
"about": {
"@type": "MedicalCondition",
"name": "Noyau accumbens",
"code": {
"@type": "MedicalCode",
"code": "D009714",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.775.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Noyau accumbens",
"alternateName": "Nucleus Accumbens",
"url": "https://questionsmedicales.fr/mesh/D009714",
"about": {
"@type": "MedicalCondition",
"name": "Noyau accumbens",
"code": {
"@type": "MedicalCode",
"code": "D009714",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.775.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Substance innominée",
"alternateName": "Substantia Innominata",
"url": "https://questionsmedicales.fr/mesh/D013377",
"about": {
"@type": "MedicalCondition",
"name": "Substance innominée",
"code": {
"@type": "MedicalCode",
"code": "D013377",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.880"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Noyau basal de Meynert",
"alternateName": "Basal Nucleus of Meynert",
"url": "https://questionsmedicales.fr/mesh/D020532",
"about": {
"@type": "MedicalCondition",
"name": "Noyau basal de Meynert",
"code": {
"@type": "MedicalCode",
"code": "D020532",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.880.100"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Noyaux gris centraux",
"alternateName": "Basal Ganglia",
"code": {
"@type": "MedicalCode",
"code": "D001479",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Clara Rodriguez-Sabate",
"url": "https://questionsmedicales.fr/author/Clara%20Rodriguez-Sabate",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain."
}
},
{
"@type": "Person",
"name": "Ingrid Morales",
"url": "https://questionsmedicales.fr/author/Ingrid%20Morales",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain."
}
},
{
"@type": "Person",
"name": "Manuel Rodriguez",
"url": "https://questionsmedicales.fr/author/Manuel%20Rodriguez",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain. mrdiaz@ull.edu.es."
}
},
{
"@type": "Person",
"name": "Sachin Manjunath",
"url": "https://questionsmedicales.fr/author/Sachin%20Manjunath",
"affiliation": {
"@type": "Organization",
"name": "Aster Medcity, Kochi, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Data-Driven Approach to Evaluate Barcode-Assisted Medication Preparation Alerts at a Large Academic Medical Center.",
"datePublished": "2023-06-24",
"url": "https://questionsmedicales.fr/article/37429757",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcjq.2023.06.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ability of machine-learning based clinical decision support system to reduce alert fatigue, wrong-drug errors, and alert users about look alike, sound alike medication.",
"datePublished": "2023-10-16",
"url": "https://questionsmedicales.fr/article/37924770",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmpb.2023.107869"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correction to: Design and evaluation of an electronic prospective medication order review system for medication orders in the inpatient setting.",
"datePublished": "2024-04-15",
"url": "https://questionsmedicales.fr/article/38628611",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/jamiaopen/ooae030"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reducing Medication Errors in Children's Hospitals.",
"datePublished": "2023-01-14",
"url": "https://questionsmedicales.fr/article/36728168",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/PTS.0000000000001087"
}
},
{
"@type": "ScholarlyArticle",
"name": "Modulators Influencing Medication Alert Acceptance: An Explorative Review.",
"datePublished": "2022-08-18",
"url": "https://questionsmedicales.fr/article/35981555",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0042-1748146"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009420"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002490"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphale",
"item": "https://questionsmedicales.fr/mesh/D001921"
},
{
"@type": "ListItem",
"position": 5,
"name": "Prosencéphale",
"item": "https://questionsmedicales.fr/mesh/D016548"
},
{
"@type": "ListItem",
"position": 6,
"name": "Télencéphale",
"item": "https://questionsmedicales.fr/mesh/D013687"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cerveau",
"item": "https://questionsmedicales.fr/mesh/D054022"
},
{
"@type": "ListItem",
"position": 8,
"name": "Noyaux gris centraux",
"item": "https://questionsmedicales.fr/mesh/D001479"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Noyaux gris centraux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Noyaux gris centraux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Noyaux gris centraux",
"description": "Comment diagnostiquer une dysfonction des noyaux gris centraux ?\nQuels tests sont utilisés pour évaluer les noyaux gris centraux ?\nQuels signes cliniques indiquent une atteinte des noyaux gris centraux ?\nLes tests génétiques sont-ils utiles pour le diagnostic ?\nQuelle est l'importance de l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Medical+Order+Entry+Systems&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Noyaux gris centraux",
"description": "Quels sont les symptômes courants des troubles des noyaux gris centraux ?\nComment se manifestent les troubles de la coordination ?\nLes troubles de la parole sont-ils liés aux noyaux gris centraux ?\nLes changements d'humeur peuvent-ils être un symptôme ?\nQuelles sont les manifestations de la rigidité musculaire ?",
"url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Medical+Order+Entry+Systems&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Noyaux gris centraux",
"description": "Peut-on prévenir les troubles des noyaux gris centraux ?\nQuel rôle joue l'alimentation dans la prévention ?\nLe contrôle du stress peut-il aider à prévenir ces troubles ?\nL'éducation sur les symptômes est-elle importante ?\nLes activités cognitives peuvent-elles prévenir les troubles ?",
"url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Medical+Order+Entry+Systems&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Noyaux gris centraux",
"description": "Quels traitements sont disponibles pour les troubles des noyaux gris centraux ?\nLes médicaments peuvent-ils soulager les symptômes ?\nQuand la chirurgie est-elle envisagée ?\nLa thérapie physique est-elle bénéfique ?\nQuels sont les effets des thérapies complémentaires ?",
"url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Medical+Order+Entry+Systems&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Noyaux gris centraux",
"description": "Quelles complications peuvent survenir avec ces troubles ?\nLes troubles cognitifs sont-ils une complication fréquente ?\nComment les troubles de la marche peuvent-ils affecter la vie quotidienne ?\nLes complications psychologiques sont-elles possibles ?\nLes complications peuvent-elles affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Medical+Order+Entry+Systems&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Noyaux gris centraux",
"description": "Quels sont les facteurs de risque pour les troubles des noyaux gris centraux ?\nLe mode de vie influence-t-il le risque ?\nLes traumatismes crâniens sont-ils un facteur de risque ?\nLes maladies auto-immunes peuvent-elles jouer un rôle ?\nL'exposition à des toxines est-elle un risque ?",
"url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Medical+Order+Entry+Systems&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des noyaux gris centraux ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur l'examen neurologique, l'imagerie cérébrale et l'historique médical."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les noyaux gris centraux ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'IRM, le scanner et des évaluations fonctionnelles spécifiques."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une atteinte des noyaux gris centraux ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des tremblements, une rigidité musculaire et des troubles de la coordination."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à identifier des maladies héréditaires affectant les noyaux gris centraux."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des antécédents familiaux ou des symptômes précurseurs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles des noyaux gris centraux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des mouvements involontaires, des troubles de l'équilibre et de la posture."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les troubles de la coordination ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils se manifestent par des difficultés à exécuter des mouvements précis et fluides."
}
},
{
"@type": "Question",
"name": "Les troubles de la parole sont-ils liés aux noyaux gris centraux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la parole peuvent survenir en raison de dysfonctionnements dans ces structures."
}
},
{
"@type": "Question",
"name": "Les changements d'humeur peuvent-ils être un symptôme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements d'humeur et des troubles cognitifs peuvent être associés à ces troubles."
}
},
{
"@type": "Question",
"name": "Quelles sont les manifestations de la rigidité musculaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La rigidité musculaire se traduit par une résistance accrue aux mouvements passifs des membres."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles des noyaux gris centraux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures de style de vie, comme l'exercice régulier, peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en antioxydants peut contribuer à la santé cérébrale."
}
},
{
"@type": "Question",
"name": "Le contrôle du stress peut-il aider à prévenir ces troubles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress peut réduire le risque de troubles neurologiques."
}
},
{
"@type": "Question",
"name": "L'éducation sur les symptômes est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une éducation précoce sur les symptômes peut favoriser un diagnostic rapide."
}
},
{
"@type": "Question",
"name": "Les activités cognitives peuvent-elles prévenir les troubles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les activités cognitives stimulantes peuvent aider à maintenir la santé cérébrale."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles des noyaux gris centraux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, la thérapie physique et, dans certains cas, la chirurgie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils soulager les symptômes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme les anticholinergiques et les dopaminergiques peuvent aider."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle envisagée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée lorsque les traitements médicamenteux ne sont pas efficaces."
}
},
{
"@type": "Question",
"name": "La thérapie physique est-elle bénéfique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle aide à améliorer la mobilité et à réduire les symptômes moteurs."
}
},
{
"@type": "Question",
"name": "Quels sont les effets des thérapies complémentaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies complémentaires peuvent aider à gérer le stress et améliorer le bien-être général."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ces troubles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des chutes, des blessures et des troubles de la déglutition."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils une complication fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cognitifs peuvent survenir, affectant la mémoire et la concentration."
}
},
{
"@type": "Question",
"name": "Comment les troubles de la marche peuvent-ils affecter la vie quotidienne ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent limiter l'autonomie et augmenter le risque de chutes et d'accidents."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications comme l'anxiété et la dépression peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent réduire la qualité de vie en limitant les activités quotidiennes."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles des noyaux gris centraux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, des antécédents familiaux et certaines maladies neurologiques."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les traumatismes crâniens sont-ils un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes crâniens peuvent augmenter le risque de troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes peuvent-elles jouer un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent affecter les noyaux gris centraux."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines environnementales peut augmenter le risque."
}
}
]
}
]
}
The purpose of this study was to develop a data-driven process to analyze barcode-assisted medication preparation alert data with a goal of minimizing inaccurate alerts....
Medication preparation data for the prior three-month period was obtained from an electronic health record system. A dashboard was developed to identify recurrent, high-volume alerts and associated me...
The institution averaged 31,000 medication preparation alerts per month. The "barcode not recognized" alert (13,000) was the highest volume over the study period. Eighty-five medication records were i...
This quality improvement project highlighted opportunities to improve medication purchasing, storage, and preparation through development of a standard process to evaluate barcode-assisted medication ...
The overall benefits of using clinical decision support systems (CDSSs) can be restrained if physicians inadvertently ignore clinically useful alerts due to "alert fatigue" caused by an excessive numb...
We conducted a retrospective study that evaluated MedGuard alerts, the alert acceptance rate, and the rate of LASA alerts between July 1, 2019, and June 31, 2021, from outpatient settings at an academ...
Over the two-year study period, 1,206,895 prescriptions were ordered and a total of 28,536 alerts were triggered (alert rate: 2.36 %). Of the 28,536 alerts presented to physicians, 13,947 (48.88 %) we...
This study shows that machine learning based CDSS, MedGuard, has an ability to improve patients' safety by triggering clinically valid alerts. This system can also help improve problem list documentat...
[This corrects the article DOI: 10.1093/jamiaopen/ooae003.]....
Knowledge of the prevalence and characteristics of medication errors in pediatric and neonatal patients is limited. This study aimed to evaluate the incidence and medication error characteristics in a...
We retrospectively reviewed medication errors documented between January 2015 and December 2019....
A total of 2,591,596 prescriptions were checked, and 255 errors were identified. Wrong dose prescriptions constituted the most common errors (56.9%). Medications with the highest rate of errors were a...
The incidence of medication errors decreased with extensive use of the CPOE system. Continuous application of the CPOE optimization program can effectively reduce medication errors. Further incorporat...
Clinical decision support systems (CDSSs) use alerts to enhance medication safety and reduce medication error rates. A major challenge of medication alerts is their low acceptance rate, limiting their...
In accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guideline, a literature search in PubMed was started in February 2018 and continued until October 202...
Out of 539 articles, 60 were included. A total of 391 single parameters were extracted (e.g., patients' comorbidity) and grouped into 75 factors (e.g., comorbidity), and 25 determinants (e.g., complex...
This review compiles modulators of alert acceptance distinguished by being studied quantitatively or qualitatively and indicates their effect magnitude whenever possible. Additionally, it describes ho...
Pseudorandomized testing can be applied to perform rigorous yet practical evaluations of clinical decision support tools. We apply this methodology to an interruptive alert aimed at reducing free-text...
The objective of this study is to evaluate the effectiveness of an interruptive alert at reducing free-text prescriptions via pseudorandomized testing using native electronic health records (EHR) func...
Two versions of an EHR alert triggered when a provider attempted to sign a discharge free-text prescription. The visible version displayed an interruptive alert to the user, and a silent version trigg...
Over the 28-week study period, 143 providers triggered 695 alerts (345 visible and 350 silent). The proportions of encounters with free-text prescriptions were 83% (266/320) and 90% (273/303) in the i...
An interruptive alert was associated with a modest reduction in free-text prescriptions. Furthermore, the majority of these prescriptions could have been reproduced using structured order entry fields...
To determine whether hospital computerised physician order entry (CPOE) systems contribute to securing intravenous potassium chloride (KCl) prescriptions with reference to the recommendations issued b...
We sent a questionnaire to the members of the Association pour le Digital et l'Information en Pharmacie....
More than three quarters of the 84 responses received involving 23 CPOE systems indicate that it is possible to : prescribe an ampoule of concentrated potassium chloride 10% 10 mL intravenously withou...
At least 23 hospital CPOE systems are unable to secure the prescriptions of injectable KCl. This finding lifts the veil on an unthought, namely the role of CPOE systems in securing high-risk medicatio...
The computerized provider order entry (CPOE) is a computing tool that could lead to unintended consequences despite its myriad benefits. We aimed to explore the effect of its inactivation on requests ...
Cross sectional study at the Emergency Department of Hospital Italiano de Buenos Aires, which included a consecutive sample of pre-intervention (January-February 2020) and post-intervention (2021) con...
There were 27,671 consultations in 2020 with a total median value of $474, and 20,819 with $1,639 in 2021. After the analysis restricted to the area of moderately complex clinics (excluding COVID-19...
Despite inflation, a significant reduction in the number of practices was achieved and overall costs per consultation were maintained. These findings demonstrate the effectiveness of the intervention,...
To evaluate the potential of a novel system using outlier detection screening algorithms and to identify medication related risks in an inpatient setting....
In the first phase of the study, we evaluated the transferability of models refined at another medical center using a different electronic medical record system (EMR) on 3 years of historical data (20...
In the retrospective phase of the study, 226,804 medical orders were analyzed, generating a total of 2731 alerts (1.2% of medical orders). Of the alerts analyzed, 69% were clinically relevant alerts a...
In an inpatient setting of a 600 bed computerized decision support system (CDSS) -naïve medical center, the system generated accurate and clinically valid alerts with low alert burden enabling physici...
To assess pharmacy student responses to medication problems with and without clinical decision support (CDS) alerts during simulated order verification....
Three classes of students completed an order verification simulation. The simulation randomized students to a different series of 10 orders with varying CDS alert frequency. Two of the orders containe...
During the first simulation, 384 students reviewed an order with a problem and an alert. Students exposed to prior inappropriate alerts within the simulation had less appropriate responses (66% vs 75%...
Some pharmacy students displayed baseline alert fatigue and overreliance on CDS alerts for medication problem detection during order verification simulations. Exposure to the simulations improved CDS ...